Get the Stockscreener App
1.97
3.06%
-0.0621
After Hours:
1.98
0.01
+0.51%
Lisata Therapeutics Inc stock is traded at $1.97, with a volume of 25,859.
It is down -3.06% in the last 24 hours and down -15.81% over the past month.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
See More
Previous Close:
$2.0321
Open:
$1.94
24h Volume:
25,859
Relative Volume:
0.41
Market Cap:
$17.38M
Revenue:
-
Net Income/Loss:
$-20.74M
P/E Ratio:
-0.7849
EPS:
-2.51
Net Cash Flow:
$-18.90M
1W Performance:
-4.37%
1M Performance:
-15.81%
6M Performance:
-25.66%
1Y Performance:
-27.04%
1-Day Range:
$1.94
$2.05
1-Week Range:
$1.85
$2.17
52-Week Range:
$1.81
$4.20
Lisata Therapeutics Inc Stock (LSTA) Company Profile
Name
Lisata Therapeutics Inc
Sector
Industry
Phone
908-229-2590
Address
110 ALLEN ROAD, BASKING RIDGE
Compare LSTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LSTA
Lisata Therapeutics Inc
|
1.97 | 17.91M | 0 | -20.74M | -18.90M | -2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lisata Therapeutics Inc Stock (LSTA) Latest News
Why institutional investors increase stakes in Lisata Therapeutics Inc. (8NE) stockJuly 2025 Market Mood & Safe Entry Momentum Tips - Newser
Why Lisata Therapeutics Inc. (8NE) stock attracts wealthy investorsJuly 2025 Recap & Growth Focused Stock Reports - Newser
Is Lisata Therapeutics Inc. (8NE) stock undervalued by metricsEarnings Overview Summary & Risk Managed Trade Strategies - Newser
Is Lisata Therapeutics Inc. stock a smart buy before Fed meetingTrade Exit Report & Consistent Profit Alerts - Newser
Can Lisata Therapeutics Inc. (8NE) stock hit consensus price targets2025 Top Decliners & Daily Growth Stock Investment Tips - Newser
Is Lisata Therapeutics Inc. (8NE) stock suitable for passive index fundsJuly 2025 Drop Watch & Verified Technical Trade Signals - Newser
Lisata Therapeutics (LSTA) Stock Analysis Report | Financials & Insights - Benzinga
Why Lisata Therapeutics Inc. stock is popular among millennials2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Will Lisata Therapeutics Inc. (8NE) stock beat revenue estimatesMarket Trend Review & Free Technical Confirmation Trade Alerts - Newser
Coastal Roadways Limited At Decision Level Rebound or ResistanceUtilities Sector Analysis & Access Free Tools and Start Investing - earlytimes.in
What analysts say about Lisata Therapeutics Inc stockMomentum Trading Signals & Market Trend Real-Time Reports - earlytimes.in
Will Lisata Therapeutics Inc. stock sustain high P E ratios2025 Risk Factors & Expert Curated Trade Setups - newser.com
Will Lisata Therapeutics Inc. (8NE) stock keep high P E multiplesJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
Lisata Therapeutics (LSTA) Price Target Decreased by 37.10% to 13.26 - MSN
Is now a turning point for Lisata Therapeutics Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Automated trading signals detected on Lisata Therapeutics Inc.Watch List & Stepwise Entry and Exit Trade Signals - newser.com
Is Lisata Therapeutics Inc. reversing from oversold territoryEarnings Growth Summary & Stock Portfolio Risk Control - newser.com
How Lisata Therapeutics Inc. (8NE) stock performs during market turbulence2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Will Lisata Therapeutics Inc. (8NE) stock see valuation expansionTrade Ideas & Free Verified High Yield Trade Plans - newser.com
Can Lisata Therapeutics Inc. stock continue upward trendJuly 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
Why Lisata Therapeutics Inc. stock is recommended by analysts2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Developing predictive dashboards with Lisata Therapeutics Inc. dataWeekly Stock Report & Safe Swing Trade Setups - newser.com
Can Lisata Therapeutics Inc. stock weather global recessionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Smart tools for monitoring Lisata Therapeutics Inc.’s price action2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Why Lisata Therapeutics Inc. stock is rated strong buyEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Using Bollinger Bands to evaluate Lisata Therapeutics Inc.2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY - TradingView
Is Lisata Therapeutics Inc. (8NE) stock cheap vs fundamentalsQuarterly Earnings Summary & Fast Gain Stock Trading Tips - newser.com
Is Lisata Therapeutics Inc. stock reversal real or fakeTrade Ideas & Intraday High Probability Setup Alerts - newser.com
Key metrics from Lisata Therapeutics Inc.’s quarterly dataJuly 2025 Volume & Consistent Profit Trading Strategies - newser.com
Can you recover from losses in Lisata Therapeutics Inc.July 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Lisata Therapeutics Inc Stock (LSTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):